One of the issues frequently popping up in debates about synthetic biology (synbio) is the possibility of introducing new and yet unknown types of biological risks.
Notions of ‘Responsible Research and Innovation’ (RRI) or ‘Responsible Innovation’ have evolved over at least ten years, both in the EU and the US.
What is the future of biotechnology? How can we create an ecosystem that integrates traditional and non-traditional actors and bolsters innovation?
On 14-15 January 2016, the European Economic and Social Committee (EESC) hosted the joint final event of 4 European projects, all working with the concept of RRI.
The RRI Toolkit has been published by the consortium of the RRI Tools project, currently in a beta version.
Synthetic biology is already being used in the processing of biomass to produce industrial goods such as biofuels, commodities for the chemical industry and ingredients for consumer goods.
What are the potential benefits and risks associated with altering human DNA? Is science and society prepared for the ethical, moral, and policy questions raised by new technological capabilities?
As part of their collaboration with SYNENERGENE, the iGEM 2014 team of Valencia Biocampus worked on questions of intelectual property in synthetic biology.
The annual international Genetically Engineered Machines student competition iGEM is a perfect match with SYNENERGENE.
I don't know if you have come across this: a completly RRI by-product of the project WormBoys developed by Valencia Biocampus Team for iGEM 2013. Ten stories about Syn-Bio, in a positive and negative version!!